These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 7024941

  • 1. [Prospective studies on the effectiveness of long-term anticoagulant treatment in coronary disease].
    Markiewicz M, Koziara Z, Florkiewicz H, Miturzyńska-Stryjecka H.
    Pol Tyg Lek; 1981 Mar 09; 36(10):369-71. PubMed ID: 7024941
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical experiences with anticoagulant long term treatment of predominantly cardiologic patients].
    Kubicek F, Praschl E.
    Wien Klin Wochenschr; 1968 Nov 01; 80(44):813-9. PubMed ID: 4974107
    [No Abstract] [Full Text] [Related]

  • 3. [The potentiation of the anticoagulant effect of acenocoumarol by cefonicid].
    Puente García M, Bécares Martínez FJ, Merlo Arroyo J, García Sánchez G, García Díaz B, Cervero Jiménez M.
    Rev Clin Esp; 1999 Sep 01; 199(9):620-1. PubMed ID: 10568163
    [No Abstract] [Full Text] [Related]

  • 4. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F, Escribá A, Maluenda MP, López Rubio M, Margalet I, Lezana A, Gallego J, Ribera JM.
    Thromb Haemost; 2000 Oct 01; 84(4):559-64. PubMed ID: 11057850
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
    Katona A, Márk L.
    Orv Hetil; 2004 Aug 08; 145(32):1643-7. PubMed ID: 15384862
    [Abstract] [Full Text] [Related]

  • 7. [Long-term anticoagulant therapy in old age].
    Bán A.
    Orv Hetil; 1984 Jan 22; 125(4):205-10. PubMed ID: 6694840
    [No Abstract] [Full Text] [Related]

  • 8. Invasive procedures in the outpatient setting: managing the short-acting acenocoumarol and the long-acting phenprocoumon.
    van Geest-Daalderop JH, Hutten BA, Péquériaux NC, de Vries-Goldschmeding HJ, Räkers E, Levi M.
    Thromb Haemost; 2007 Oct 22; 98(4):747-55. PubMed ID: 17938797
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low molecular weight heparin (nadroparine) versus oral anticoagulant (acenocoumarol) in the long-term treatment of deep venous thrombosis: comparison of efficacy, safety and hospitalisation period in 105 patients.
    Mazokopakis EE, Vrentzos GE, Ganotakis ES.
    Curr Med Res Opin; 2003 Oct 22; 19(6):565-6. PubMed ID: 14594529
    [Abstract] [Full Text] [Related]

  • 11. [Long-term application of warfarin or acenocumarol in patients with fibrillating arrhythmia: the effects compared].
    Kropacheva ES, Panchenko EP, Ataullakhanova DM.
    Klin Med (Mosk); 2005 Oct 22; 83(1):24-7. PubMed ID: 15759486
    [Abstract] [Full Text] [Related]

  • 12. Patients who take uneven doses of acenocoumarol exhibit significant fluctuating levels of anticoagulation.
    Marco F, Gutiérrez JI, Orkolaga K, Márquez JA, Ojínaga MJ, de Zárate IO, de Heredia JM.
    Blood Coagul Fibrinolysis; 2006 Sep 22; 17(6):509-12. PubMed ID: 16905959
    [Abstract] [Full Text] [Related]

  • 13. Kinetic study of factor X during oral anticoagulation with acenocoumarol: potential value for the initiation of treatment.
    Aiach M, Fiessinger JN, Capron L, Nussas C, Housset E, Leclerc M.
    Thromb Haemost; 1982 Feb 26; 47(1):69-71. PubMed ID: 7071808
    [No Abstract] [Full Text] [Related]

  • 14. Rosuvastatin-acenocoumarol interaction.
    Mondillo S, Ballo P, Galderisi M.
    Clin Ther; 2005 Jun 26; 27(6):782-4. PubMed ID: 16117985
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK, Rosendaal FR, van der Meer FJ.
    Thromb Haemost; 2009 Mar 26; 101(3):552-6. PubMed ID: 19277419
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Hemorrhagic incidents during prolonged ambulatory treatment with acenocoumarol].
    Reverter JC, Tàssies D, Maragall S, Monteagudo J, Escolar G, Ordinas A.
    Med Clin (Barc); 1995 Jun 24; 105(4):127-30. PubMed ID: 7623503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.